Researchers at the University of Virginia are using artificial intelligence to explore new uses for existing medications, potentially revolutionizing the treatment of heart disease.
A new collaboration between Philips and Medtronic in India aims to upskill clinicians in advanced imaging techniques to improve the diagnosis and treatment of structural heart diseases, especially for patients with End-Stage Renal Disease.
